US Stock MarketDetailed Quotes

SVRA Savara

Watchlist
  • 4.080
  • +0.020+0.49%
Close Jun 14 16:00 ET
  • 4.150
  • +0.070+1.72%
Post 17:41 ET
563.81MMarket Cap-11027P/E (TTM)

About Savara Company

Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in December 1995 and is headquartered in Langhorne, PA.

Company Profile

SymbolSVRA
Company NameSavara
Listing DateApr 29, 2004
Founded1995
CEOMr. Matthew Pauls
MarketNASDAQ
Employees37
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1717 Langhorne Newtown Road,Suite 302
CityLanghorne
ProvincePennsylvania
CountryUnited States of America
Zip Code19047
Phone1-512-614-1848
Websitehttp://www.savarapharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Matthew Pauls
  • Chairman of the Board and Chief Executive Officer
  • 3.76M
  • Anne Erickson
  • Chief Business Officer
  • --
  • David L. Lowrance
  • Chief Accounting Officer, Chief Financial and Administrative Officer
  • 1.52M
  • Robert Lutz
  • Chief Operating Officer
  • 2.66M
  • Dr. Raymond Pratt
  • Chief Medical Officer
  • --
  • Richard J. Hawkins
  • Independent Director
  • 149.13K
  • Nevan Charles Elam, J.D.
  • Independent Director
  • 157.63K
  • David A. Ray
  • Independent Director
  • 158.13K
  • Dr. An van Es-Johansson, M.D.
  • Independent Director
  • 155.63K
  • Dr. Ricky L. Sun, PhD
  • Independent Director
  • 144.63K
  • Dr. Joseph S. McCracken, D.V.M.
  • Lead Independent Director
  • 155.13K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg